Efficient Human Immunodeficiency Virus Replication Requires a Fine-Tuned Level of Transcription

ABSTRACT Transcription represents a crucial step in the life cycle of human immunodeficiency virus (HIV) and is highly regulated. Here we show that the strength of the viral long terminal repeat (LTR) promoter is optimized for efficient replication. Artificially increasing the rate of LTR-driven transcription was strongly detrimental for viral fitness, and HIV was able to regain replication capacity by selecting for variants with a weaker LTR. Strikingly, the strength of the evolved promoter was equivalent to that of the wild-type LTR.

[1]  A. Telesnitsky,et al.  Replication of Lengthened Moloney Murine Leukemia Virus Genomes Is Impaired at Multiple Stages , 2000, Journal of Virology.

[2]  B. Berkhout,et al.  Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat , 2001, Journal of Virology.

[3]  H. Will,et al.  The tetracycline-responsive promoter contains functional interferon-inducible response elements. , 2000, Nucleic acids research.

[4]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[5]  R. Gaynor,et al.  Cellular transcription factors involved in the regulation of HIV-1 gene expression. , 1992, AIDS.

[6]  K. Jeang,et al.  Constitutively Dead, Conditionally Live HIV-1 Genomes , 2001, The Journal of Biological Chemistry.

[7]  H. Bujard,et al.  Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. , 2000, Methods in enzymology.

[8]  A. Das,et al.  HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro. , 1999, Virology.

[9]  M. V. van Dooren,et al.  Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O , 2001, Journal of Clinical Microbiology.

[10]  E. Ross,et al.  DNA constraints on transcription activation in vitro. , 2000, Journal of molecular biology.

[11]  W. Keulen,et al.  Reduced replication of 3TC‐resistant HIV‐1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. , 1996, The EMBO journal.

[12]  B. Berkhout,et al.  Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains , 1999, Journal of Virology.

[13]  F. McCutchan,et al.  Understanding the genetic diversity of HIV-1. , 2000, AIDS.

[14]  T. Miura,et al.  Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. , 2000, Virology.

[15]  B. Berkhout,et al.  Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G , 2000, Journal of Virology.

[16]  B. Berkhout,et al.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target , 1989, Cell.

[17]  M. Churchill,et al.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. , 2000, Nucleic acids research.

[18]  B. Berkhout,et al.  In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies , 2001, Proceedings of the National Academy of Sciences of the United States of America.